Can Eliquis Play Catch Up? New Indication Should Help
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer and Bristol-Myers Squibb’s Eliquis is now approved for a new use after orthopedic surgery. In competition with the broadly labeled Xarelto and Boehringer’s Pradaxa, Eliquis had a slower than expected launch, but has been performing better recently.